AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE PLUS RITUXIMAB TREATMENT IN CLL PATIENTS

被引：0
|
作者：
Laurenti, L. [1 ]
Autore, F. [1 ]
Innocenti, I. [1 ]
D'Arena, G. [2 ]
Coscia, M. [3 ]
Mondello, P. [4 ]
Bellesi, S. [1 ]
Efremov, D. [5 ]
Sica, S. [1 ]
Mauro, F. R. [6 ]
机构：
[1] Univ Cattolica Sacro Cuore, A Gemelli Policlin, I-00168 Rome, Italy
[2] IRCCS Ctr Riferimento Oncol Basilicata, Rionero In Vulture, PZ, Italy
[3] AO Citta Salute & Sci S Giovanni Battista, Turin, Italy
[4] Univ Messina, Dept Human Pathol, Messina, Italy
[5] Monterotondo Scalo, Int Ctr Genet Engn & Biotechnol, Rome, Italy
[6] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P197
引用
收藏
页码：133 / 133
页数：1
相关论文
共 50 条
  • [31] Autoimmune haemolytic anaemia in patients with chronic myeloid leukaemia during treatment with interferon-α:: a report of three cases
    Celeketic, DC
    Nadaskic, R
    ALLERGY, 2002, 57 : 162 - 162
  • [32] Successful Management of Rituximab Refractory Warm Autoimmune Haemolytic Anaemia with Splenectomy: A Case Report
    Ansari, Zuber
    Akhtar, Suhail
    Ahmed, Anas
    Bhati, Sumera
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2024, 18 (08)
  • [33] Long lasting remission by rituximab in a patient with primary cold agglutinin autoimmune haemolytic anaemia
    Glaser, Marjana
    Glaser, Andrej
    Skalicky, Marjan
    WIENER KLINISCHE WOCHENSCHRIFT, 2011, 123 (21-22) : 680 - 683
  • [34] A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia
    Birgens, Henrik
    Frederiksen, Henrik
    Hasselbalch, Hans C.
    Rasmussen, Inge H.
    Nielsen, Ove J.
    Kjeldsen, Lars
    Larsen, Herdis
    Mourits-Andersen, Torben
    Plesner, Torben
    Ronnov-Jessen, Dorthe
    Vestergaard, Hanne
    Klausen, Tobias W.
    Schollkopf, Claudia
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (03) : 393 - 399
  • [35] Health-related quality-of-life in treatment-naive CLL/SLL patients treated with zanubrutinib versus bendamustine plus rituximab
    Ghia, Paolo
    Barnes, Gisoo
    Yang, Keri
    Tam, Constantine S.
    Robak, Tadeusz
    Brown, Jennifer R.
    Kahl, Brad S.
    Tian, Tian
    Szeto, Andy
    Paik, Jason C.
    Shadman, Mazyar
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (11) : 1505 - 1511
  • [36] Autoimmune haemolytic anaemia responding to anti-tuberculous treatment
    Siribaddana, SH
    Wijesundera, A
    TROPICAL DOCTOR, 1997, 27 (04) : 243 - 244
  • [37] Bendamustine Plus Rituximab for the Treatment of Waldenstrom Macroglobulinaemia: Patient Outcomes and Impact of Bendamustine Dosing
    Arulogun, Suzanne O.
    Brian, Duncan
    Goradia, Harshita
    Cooney, Aaron
    Menne, Tobias
    Talaulikar, Dipti
    O'Neill, Aideen Therese
    Vos, Josephine M. I.
    Pratt, Guy
    Turner, Deborah
    Marshall, Kirsty
    Manos, Kate
    Anderson, Claire
    Gavriatopoulou, Maria
    Kyriakou, Charalampia
    Minnema, Monique C.
    El-Sharkawi, Dima
    Kersten, Marie Jose
    Koo, RayMun
    McCarthy, Helen
    Bishton, Mark
    Follows, George
    Wechalekar, Ashutosh D.
    D'Sa, Shirley
    BLOOD, 2020, 136
  • [38] Improvement of Quality of Response with Ibrutinib Plus Bendamustine/Rituximab Vs Placebo Plus Bendamustine/Rituximab for Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
    Cramer, Paula
    Chanan-Khan, Asher
    Fraser, Graeme
    Demirkan, Fatih
    Silva, Rodrigo Santucci
    Pylypenko, Halyna
    Grosicki, Sebastian
    Janssens, Ann
    Goy, Andre
    Mayer, Jiri
    Dilhuydy, Marie Sarah
    Loscertales, Javier
    Bartlett, Nancy L.
    Avigdor, Abraham
    Rule, Simon
    Sun, Steven
    Phelps, Charles
    Mahler, Michelle
    Salman, Mariya
    Schaffer, Michael
    Balasubramanian, Sriram
    Howes, Angela
    Hallek, Michael
    BLOOD, 2015, 126 (23)
  • [39] Bendamustine plus rituximab for the treatment of Waldenstrom Macroglobulinemia: Patient outcomes and impact of bendamustine dosing
    Arulogun, Suzanne O.
    Brian, Duncan
    Goradia, Harshita
    Cooney, Aaron
    Menne, Tobias
    Koo, RayMun
    O'Neill, Aideen T.
    Vos, Josephine M. I.
    Pratt, Guy
    Turner, Deborah
    Marshall, Kirsty
    Manos, Kate
    Anderson, Claire
    Gavriatopoulou, Maria
    Kyriakou, Charalampia
    Kersten, Marie J.
    Minnema, Monique C.
    Koutoumanou, Eirini
    El-Sharkawi, Dima
    Linton, Kim
    Talaulikar, Dipti
    McCarthy, Helen
    Bishton, Mark
    Follows, George
    Wechalekar, Ashutosh
    D'Sa, Shirley P.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (05) : 750 - 759
  • [40] Bendamustine plus rituximab in untreated chronic lymphocytic leukemia patients. The MDA-CLL-2015-02 study
    De La Fuente, Adolfo
    Navas, Begona
    Gutierrez, Antonio
    Jose Terol, Maria
    Callejas, Marta
    Garcia Marco, Jose Antonio
    Dolores Garcia-Malo, Maria
    de la Serna, Javier
    Teresa Gonzalez-Gascon y Marin, Isabel
    Sanchis, Laura Garcia
    Ballesteros, Monia
    Benavente, Celina
    Jarque, Isidro
    Ochoa Gullon, Juliana
    Beneit, Paola
    de Ona, Raquel
    Montalabn, Carlos
    Estevez, Monica
    Iglesias, Rebeca
    Diaz-Lopez, Antonio
    Baltasar, Patricia
    LEUKEMIA & LYMPHOMA, 2017, 58 : 200 - 201
12345